[vc_row][vc_column width=”3/4″][vc_message]The Europe antihypertensive drugs market is estimated to grow at a CAGR of 2.70% during the forecast period of 2019-2028. Europe accounted for the second-largest revenue share across the antihypertensive drugs market, due to key drivers like solid traction of significant players in the region and awareness regarding antihypertensive drugs to treat hypertension. [/vc_message][vc_row_inner…
The North America antihypertensive drugs market is predicted to record a CAGR of 3.28% during the forecast years of 2019 to 2028. Get a Free Sample Report.
[vc_row][vc_column][vc_column_text] [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”3/4″][vc_message]In terms of revenue, the global VR in healthcare market was valued at $xx billion in 2021 and is expected to reach $4.58 billion by 2030, growing at a CAGR of 30.62% during the forecast period. The market study has also analyzed the impact of COVID-19 on the global VR in healthcare market…
The Asia-Pacific VR in healthcare market is expected to develop with a CAGR of 32.10%, during the forecasting years of 2022-2030. Request a Free Sample Report
[vc_row][vc_column width=”3/4″][vc_message]The Europe VR in healthcare market is estimated to register a CAGR of 30.76% across the projected years of 2022 to 2030, acquiring a revenue share of $1266.06 million by 2030. [/vc_message][vc_row_inner el_class=”an-report-custom-heading” css=”.vc_custom_1505382055404{margin-bottom: 32px !important;}”][vc_column_inner width=”1/6″][vc_single_image image=”7478″][/vc_column_inner][vc_column_inner width=”5/6″][vc_column_text] EUROPE VR IN HEALTHCARE MARKET FORECAST 2022-2030 Europe VR in Healthcare Market by End-user (Hospitals…